KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Debt to Equity (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Debt to Equity for 13 consecutive years, with $0.01 as the latest value for Q4 2025.

  • Quarterly Debt to Equity fell 70.59% to $0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.01 through Dec 2025, down 70.59% year-over-year, with the annual reading at $0.01 for FY2025, 70.59% down from the prior year.
  • Debt to Equity for Q4 2025 was $0.01 at Biolife Solutions, down from $0.02 in the prior quarter.
  • The five-year high for Debt to Equity was $0.08 in Q1 2023, with the low at $0.0 in Q1 2021.
  • Average Debt to Equity over 5 years is $0.04, with a median of $0.04 recorded in 2024.
  • The sharpest move saw Debt to Equity plummeted 98.32% in 2021, then soared 378.61% in 2022.
  • Over 5 years, Debt to Equity stood at $0.02 in 2021, then skyrocketed by 365.87% to $0.07 in 2022, then grew by 0.44% to $0.07 in 2023, then tumbled by 35.31% to $0.05 in 2024, then tumbled by 70.59% to $0.01 in 2025.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.01, $0.02, and $0.03 for Q4 2025, Q3 2025, and Q2 2025 respectively.